OCGN insider filings
Ocugen, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-13. Screen OCGN transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings by 1 insider — 1,051,982 shares, $1,088,801 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 468,727 shares @ $1.12 ($524,974) by Musunuri Shankar, filed 2026-09-11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Musunuri Shankar — Chief Executive Officer, Director | 2 | — | 4 legs · 1,051,982 sh · $1,088,801 | — |
Recent insider filings — Ocugen, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Sale (S): 468,727 @ $0.95 · Sale (S): 57,264 @ $0.95 | EDGAR |
| 2026-09-11 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Sale (S): 468,727 @ $1.12 · Sale (S): 57,264 @ $1.12 | EDGAR |
| 2026-06-17 | 4 | Johnson-Greene Treerita Essalima — Chief Financial Officer | Purchase (P): 21,000 @ $1.23 | EDGAR |
| 2026-06-15 | 4 | Kompella Uday — Director | Grant/award (A): 170,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Chandrasekhar Satishchandran — Director | Grant/award (A): 170,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Castillo Kirsten — Director | Grant/award (A): 170,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Zhang Junge — Director | Grant/award (A): 170,100 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Coleman Blaise — Director | Grant/award (A): 170,100 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Zhang Junge — Director | Option exercise (M): 15,000 @ $0.51 · Option exercise (M): 112,205 @ $0.46 · Option exercise (M): 66,929 @ $1.42 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 112,205 (derivative) @ $0 · Option exercise (M): 66,929 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Grant/award (A): 3,123,201 @ $0 · Grant/award (A): 3,123,201 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Ramachandran Ramesh — Chief Accounting Officer | Grant/award (A): 207,300 @ $0 · Grant/award (A): 310,950 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Chandrasekhar Satishchandran — Director | Grant/award (A): 151,316 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Coleman Blaise — Director | Grant/award (A): 151,316 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Castillo Kirsten — Director | Grant/award (A): 151,316 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Kompella Uday — Director | Grant/award (A): 151,316 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Zhang Junge — Director | Grant/award (A): 151,316 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Ramachandran Ramesh — Chief Accounting Officer | Grant/award (A): 350,146 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Upadhyay Arun — See Remarks | Tax withholding (F): 41,633 @ $0.89 · Grant/award (A): 730,994 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Tax withholding (F): 177,146 @ $0.89 · Grant/award (A): 1,827,485 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Qamar Huma — Chief Medical Officer | Grant/award (A): 1,145,468 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Fernandes Prabhavathi — Director | Purchase (P): 10,000 @ $0.91 | EDGAR |
| 2024-11-26 | 4 | Castillo Kirsten — Director | Purchase (P): 25,000 @ $0.91 | EDGAR |
| 2024-09-26 | 4 | Upadhyay Arun — See Remarks | Tax withholding (F): 842 @ $1.17 | EDGAR |
| 2024-07-02 | 4 | Kompella Uday — Director | Grant/award (A): 66,929 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Castillo Kirsten — Director | Grant/award (A): 66,929 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Zhang Junge — Director | Grant/award (A): 66,929 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Fernandes Prabhavathi — Director | Grant/award (A): 66,929 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Upadhyay Arun — See Remarks | Tax withholding (F): 917 @ $1.42 | EDGAR |
| 2024-07-02 | 4 | WHITTINGTON MARNA C — Director | Grant/award (A): 66,929 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | Qamar Huma — Chief Medical Officer | Grant/award (A): 308,465 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Tax withholding (F): 180,204 @ $0.65 | EDGAR |
| 2024-01-05 | 4 | Upadhyay Arun — See Remarks | Tax withholding (F): 41,633 @ $0.65 | EDGAR |
| 2024-01-04 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Grant/award (A): 492,126 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | Upadhyay Arun — See Remarks | Grant/award (A): 137,795 (derivative) @ $0 | EDGAR |
| 2023-09-19 | 4 | Upadhyay Arun — See Remarks | Tax withholding (F): 842 @ $0.41 | EDGAR |
| 2023-06-20 | 4 | Upadhyay Arun — Chief Scientific Officer | Tax withholding (F): 917 @ $0.51 | EDGAR |
| 2023-06-16 | 4 | Zhang Junge — Director | Purchase (P): 200,278 @ $0.50 | EDGAR |
| 2023-06-09 | 4 | Castillo Kirsten — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Fernandes Prabhavathi — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Kompella Uday — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Kumar Ramesh — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Zhang Junge — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | WHITTINGTON MARNA C — Director | Grant/award (A): 112,205 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Upadhyay Arun — Chief Scientific Officer | Tax withholding (F): 7,102 @ $1.25 | EDGAR |
| 2023-02-17 | 4 | Crespo Jessica — CAO/SVP, Finance | Tax withholding (F): 1,913 @ $1.25 | EDGAR |
| 2023-02-17 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Tax withholding (F): 37,877 @ $1.25 · Option exercise (M): 100,000 @ $0.33 · Sale (S): 100,000 @ $1.08 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Option exercise (M): 100,000 @ $0.51 · Sale (S): 100,000 @ $1.28 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Upadhyay Arun — Chief Scientific Officer | Grant/award (A): 315,924 @ $0 · Grant/award (A): 379,357 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Crespo Jessica — CAO/SVP, Finance | Grant/award (A): 122,951 @ $0 · Grant/award (A): 147,638 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Musunuri Shankar — Chief Executive Officer, Director | Grant/award (A): 1,475,410 @ $0 · Grant/award (A): 1,771,654 (derivative) @ $0 | EDGAR |
Recent 8-K events — Ocugen, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OCGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs